The effort is part of the Inflation Reduction Act, put in place by the administration in 2022, which outlines lowering drug prices and capping out-of-pocket medication costs as part of its aim. In the update, the administration calls out drugmakers for raising prices “faster than the rate of inflation.”
“Discouraging drug companies from price increases above the rate of inflation is a key part of this effort, and CMS continues to implement the law to bring savings to people with Medicare,” CMS Administrator Chiquita Brooks-LaSure, said in a news release.
The price cuts on the 64 drugs will run through Sept. 30. During this time, patients could save between $1 and $4,593 per day.
Earlier this year, CMS selected drugmakers to begin price negotiations for 10 of the most expensive drugs in the U.S. as part of related efforts.
Next, in 2025, as part of further Medicare Prescription Drug Inflation Rebate Program actions, Medicare Part D enrollees who have yearly out-of-pocket costs capped at $3,500 will see that drop to $2,000.
The 64 drugs available to Medicare Part B enrollees at discounted rates for a limited time are:
- Abecma
- Abilify Maintena
- Adcetris
- Akynzeo capsule
- Atgam
- Aveed
- Beleodaq
- Bicillin C-R
- Bicillin L-A
- Blincyto
- Breyanzi
- Briumvi
- Cefepime
- Chirhostim
- Cresemba
- Crysvita
- Cuvitru
- Cytogam
- Envarsus Xr
- Evenity
- Fosaprepitant
- Fragmin
- Fyarro
- Gemcitabine
- Imlygic
- Ixempra
- Kepivance
- Kimmtrak
- Kinevac
- Krystexxa
- Kymriah
- Kyprolis
- Leukine
- Lupron Depot-Ped
- Meropenem
- Minocin
- Nexterone
- Nipent
- Nplate
- Nuzyra
- Oncaspar
- Orbactiv
- Padcev
- Panhematin
- Prolia
- Rybrevant
- Rylaze
- Signifor Lar
- Sotalol
- Sylvant
- Tigan
- Tivdak
- Trogarzo
- Vabomere
- Vectibix
- Vivitrol
- Vyepti
- Vyxeos
- Xerava
- Xiaflex
- Yescarta
- Zemdri
- Zerbaxa
- Zoladex
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
